Detalhe da pesquisa
1.
Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma.
Ann Hematol
; 102(2): 369-383, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36460794
2.
Clinical and Neuroimaging Correlates of Post-Transplant Delirium.
Biol Blood Marrow Transplant
; 26(12): 2323-2328, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961373
3.
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32015031
4.
Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma.
Biol Blood Marrow Transplant
; 23(2): 262-268, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27856369
5.
Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization.
Biol Blood Marrow Transplant
; 23(7): 1151-1157, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28392378
6.
Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning.
Biol Blood Marrow Transplant
; 23(11): 1949-1954, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28729147
7.
Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma.
Hematol Oncol
; 35(4): 752-759, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28105753
8.
Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial.
Clin Infect Dis
; 63(8): 999-1006, 2016 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27481873
9.
Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients.
J Clin Apher
; 30(1): 1-7, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24941931
10.
Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma.
J Clin Apher
; 30(3): 176-82, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25293363
11.
Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies.
Biol Blood Marrow Transplant
; 20(2): 257-63, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24269380
12.
Financial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis.
JCO Oncol Pract
; 20(3): 351-360, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127876
13.
A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma.
Cancer Invest
; 31(3): 172-6, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23406188
14.
A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.
Transplant Cell Ther
; 29(3): 179.e1-179.e10, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577483
15.
Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 18(11): 1664-1676.e1, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22698485
16.
Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant
; 57(1): 89-94, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34667271
17.
Home-Based Hematopoietic Cell Transplantation in the United States.
Transplant Cell Ther
; 28(4): 207.e1-207.e8, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35066211
18.
Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years.
Transplant Cell Ther
; 28(8): 498.e1-498.e9, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595226
19.
Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.
Biol Blood Marrow Transplant
; 17(6): 867-74, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20868761
20.
Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors.
Cancer Invest
; 29(1): 56-61, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21166499